Dupixent 300 MG/2 ML syringe 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F7CU8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,375
Award facts
- Contract value 100% obligated
- $11,374.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,374.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Dupixent 300 mg/2 ml syringes. This is a non-set-aside competitive award with a completion date of January 30, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Dupixent is a biologic medication used to treat various inflammatory conditions including eczema, asthma, and chronic rhinosinusitis. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving federal government healthcare systems, particularly the military and veteran populations.
This delivery order was issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 31, 2031. This comprehensive IDC enables the delivery of a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. The structure of this delivery order exemplifies the efficient procurement model under which the Defense Logistics Agency fulfills critical pharmaceutical needs for military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F7CU8?
SPE2DR26F7CU8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 29, 2026.
How much is contract SPE2DR26F7CU8 worth?
The government has obligated $11,375 on SPE2DR26F7CU8.
Is contract SPE2DR26F7CU8 an order under another contract?
Yes. SPE2DR26F7CU8 is a delivery order under SPE2DR25D3504, an indefinite delivery contract.
Was contract SPE2DR26F7CU8 competed?
The extent of competition for SPE2DR26F7CU8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award